Cargando…
Tissue-specific cancer stem/progenitor cells: Therapeutic implications
Surgical resection, chemotherapy, and radiation are the standard therapeutic modalities for treating cancer. These approaches are intended to target the more mature and rapidly dividing cancer cells. However, they spare the relatively quiescent and intrinsically resistant cancer stem cells (CSCs) su...
Autores principales: | Yehya, Amani, Youssef, Joe, Hachem, Sana, Ismael, Jana, Abou-Kheir, Wassim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277968/ https://www.ncbi.nlm.nih.gov/pubmed/37342220 http://dx.doi.org/10.4252/wjsc.v15.i5.323 |
Ejemplares similares
-
Drug resistance in metastatic castration-resistant prostate cancer: an update on the status quo
por: Yehya, Amani, et al.
Publicado: (2022) -
Cancer Stem Cells in Neuroblastoma: Expanding the Therapeutic Frontier
por: Bahmad, Hisham F., et al.
Publicado: (2019) -
The Akt/mTOR pathway in cancer stem/progenitor cells is a potential therapeutic target for glioblastoma and neuroblastoma
por: Bahmad, Hisham F., et al.
Publicado: (2018) -
MicroRNAs as clinical tools for diagnosis, prognosis, and therapy in prostate cancer
por: Ghamlouche, Fatima, et al.
Publicado: (2023) -
Metformin and Ara-a Effectively Suppress Brain Cancer by Targeting Cancer Stem/Progenitor Cells
por: Mouhieddine, Tarek H., et al.
Publicado: (2015)